Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Igor Palacios

Showing results (31-40 of 51) with videos related to

Pageof 6
Sort By:
The American Journal of Cardiology|May 14, 2020
Comparison of Outcomes of Alcohol Septal Ablation or Septal Myectomy for Hypertrophic Cardiomyopathy in Patients ≤65 Years Versus >65 YearsAlejandro Lemor, Pedro A Villablanca, Seyed Hamed Hosseini Dehkordi, et al.
American Heart Journal|February 3, 2009
Predictive factors for in-stent late loss and coronary lesion progression in patients with type 2 diabetes mellitus randomized to rosiglitazone or placeboAloke V Finn, Jae S Oh, Michael Hendricks, et al.
CJC Open|July 19, 2024
Acute Coronary Syndrome During the Era of COVID-19: Perspective and Implications Using Google TrendsJuan A Quintero-Martinez, Joaquin Espinoza, Diego Celli, et al.
The American Journal of Cardiology|February 15, 2014
Impact of hemodynamic support with Impella 2.5 versus intra-aortic balloon pump on prognostically important clinical outcomes in patients undergoing high-risk percutaneous coronary intervention (from the PROTECT II randomized trial)George D Dangas, Annapoorna S Kini, Samin K Sharma, et al.
The American Journal of Cardiology|July 7, 2012
Management strategy in 249 consecutive patients with obstructive hypertrophic cardiomyopathy referred to a dedicated programRichard D Rothman, Aaron L Baggish, Caitlin O'Callaghan, et al.
The American Journal of Cardiology|September 26, 2016
Comparison of Outcomes of Transcatheter Aortic Valve Replacement Plus Percutaneous Coronary Intervention Versus Transcatheter Aortic Valve Replacement Alone in the United StatesVikas Singh, Alex P Rodriguez, Badal Thakkar, et al.
Journal of the American College of Cardiology|April 25, 2006
Oral rapamycin after coronary bare-metal stent implantation to prevent restenosis: the Prospective, Randomized Oral Rapamycin in Argentina (ORAR II) StudyAlfredo E Rodriguez, Juan F Granada, Máximo Rodriguez-Alemparte, et al.
International Journal of Cardiology|April 6, 2017
Outcomes of hemodynamic support with Impella in very high-risk patients undergoing balloon aortic valvuloplasty: Results from the Global cVAD RegistryVikas Singh, Pradeep K Yadav, Marvin H Eng, et al.
JAMA Cardiology|November 21, 2019
Association of Pulmonary Hypertension With Clinical Outcomes of Transcatheter Mitral Valve RepairRasha Al-Bawardy, Sreekanth Vemulapalli, Vinod H Thourani, et al.
Clinical Proteomics|February 14, 2015
Proteomic signatures of serum albumin-bound proteins from stroke patients with and without endovascular closure of PFO are significantly different and suggest a novel mechanism for cholesterol effluxMary F Lopez, Bryan Krastins, David A Sarracino, et al.
Pageof 6

Showing results (31-40 of 51) with videos related to

Sort By:
Pageof 6
The American Journal of Cardiology|May 14, 2020
Comparison of Outcomes of Alcohol Septal Ablation or Septal Myectomy for Hypertrophic Cardiomyopathy in Patients ≤65 Years Versus >65 YearsAlejandro Lemor, Pedro A Villablanca, Seyed Hamed Hosseini Dehkordi, et al.
American Heart Journal|February 3, 2009
Predictive factors for in-stent late loss and coronary lesion progression in patients with type 2 diabetes mellitus randomized to rosiglitazone or placeboAloke V Finn, Jae S Oh, Michael Hendricks, et al.
CJC Open|July 19, 2024
Acute Coronary Syndrome During the Era of COVID-19: Perspective and Implications Using Google TrendsJuan A Quintero-Martinez, Joaquin Espinoza, Diego Celli, et al.
The American Journal of Cardiology|February 15, 2014
Impact of hemodynamic support with Impella 2.5 versus intra-aortic balloon pump on prognostically important clinical outcomes in patients undergoing high-risk percutaneous coronary intervention (from the PROTECT II randomized trial)George D Dangas, Annapoorna S Kini, Samin K Sharma, et al.
The American Journal of Cardiology|July 7, 2012
Management strategy in 249 consecutive patients with obstructive hypertrophic cardiomyopathy referred to a dedicated programRichard D Rothman, Aaron L Baggish, Caitlin O'Callaghan, et al.
The American Journal of Cardiology|September 26, 2016
Comparison of Outcomes of Transcatheter Aortic Valve Replacement Plus Percutaneous Coronary Intervention Versus Transcatheter Aortic Valve Replacement Alone in the United StatesVikas Singh, Alex P Rodriguez, Badal Thakkar, et al.
Journal of the American College of Cardiology|April 25, 2006
Oral rapamycin after coronary bare-metal stent implantation to prevent restenosis: the Prospective, Randomized Oral Rapamycin in Argentina (ORAR II) StudyAlfredo E Rodriguez, Juan F Granada, Máximo Rodriguez-Alemparte, et al.
International Journal of Cardiology|April 6, 2017
Outcomes of hemodynamic support with Impella in very high-risk patients undergoing balloon aortic valvuloplasty: Results from the Global cVAD RegistryVikas Singh, Pradeep K Yadav, Marvin H Eng, et al.
JAMA Cardiology|November 21, 2019
Association of Pulmonary Hypertension With Clinical Outcomes of Transcatheter Mitral Valve RepairRasha Al-Bawardy, Sreekanth Vemulapalli, Vinod H Thourani, et al.
Clinical Proteomics|February 14, 2015
Proteomic signatures of serum albumin-bound proteins from stroke patients with and without endovascular closure of PFO are significantly different and suggest a novel mechanism for cholesterol effluxMary F Lopez, Bryan Krastins, David A Sarracino, et al.
Pageof 6